Financials
Financial year 2025
GSK-Beheer from Hasselt, company number BE0871717917, closed financial year 2025 with a result of € 104,180 after tax. For that financial year GSK-Beheer recorded a gross margin of € 155,313 and equity of € 514,184. Compared with financial year 2024, the result moved from € -376 to € 104,180. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 25, 2026.
€ 514,184
▲ 4% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 104,180
▲ still € 376 loss in 2024
Profit after tax over the fiscal year.
€ 30,560
▼ 28% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 85,000 paid out
82 % of the profit went to the shareholders, mostly to GSK INVESTMENT COMPANY (100 % of the shares). That is where the money ends up.
People and assets in 2025
€ 26,395
▲ 2% vs 2024
Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
Debts at end 2025
€ 829,587
▼ 5% vs 2024
€ 41,934 is repaid this year. At this pace the long-term loan is gone in ≈ 20 years.
€ 3,222
▲ 148% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 11,963
▼ 5% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 98,148 | € 38,997 | € 55,580 | € 155,313 | ▲ 179% |
| Profit after taxes | € -36,569 | € -13,934 | € -376 | € 104,180 | ▲ € 104,557 |
| Equity | € 759,314 | € 745,380 | € 495,004 | € 514,184 | ▲ 4% |
| Total debts | € 742,794 | € 680,332 | € 884,572 | € 929,771 | ▲ 5% |
| Cash | € 212,842 | € 175,600 | € 42,338 | € 30,560 | ▼ 28% |
| Land & buildings | € 741,863 | € 730,365 | € 712,350 | € 705,208 | ▼ 1% |
| Retained profit | € 740,714 | € 726,780 | € 476,404 | € 495,584 | ▲ 4% |
| Dividend | € 0 | € 0 | € 250,000 | € 85,000 | ▼ 66% |
| Bank debt | € 691,836 | € 653,654 | € 870,642 | € 829,587 | ▼ 5% |
| Balance sheet total | € 1,542,587 | € 1,464,457 | € 1,416,585 | € 1,479,230 | ▲ 4% |
Key figures of GSK-Beheer, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to GSK-Beheer?
What happened at GSK-Beheer in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 104,180. Source: NBB ↗
- Start of the company according to the CBE. KBO
- New establishment in Hasselt. KBO
In short
From € 36,569 loss in 2022 to € 104,180 profit in 2025.
Paid € 52,950 in corporate taxes since 2022.
Best year ever: 2025, with € 104,180 profit.
Paid out € 335,000 in dividends to the owners in total.
A new publication or filing at GSK-Beheer? We notify you, reason included.
Follow GSK-BeheerDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The stake of GSK INVESTMENT COMPANY comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
GSK-BeheerBehind GSK-Beheer is Gsk Investment Company BV. The shares are held by GSK INVESTMENT COMPANY (100%).
Directors
According to the 2025 annual accounts
Director · represented by Dries Peeters
Also active at: CS-CONTRACTING, Peeters Dries Beheer
Shareholders
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Guffenslaan 44
3500 Hasselt
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 5 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0871.717.917
- VAT number
- BE 0871.717.917
- Registered office
- Guffenslaan 44, 3500 Hasselt
- Names & denominations
- GSK-Beheer
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 7 February 2005
- Peppol
- Active · Active since 19 Jan 2026
- Activities · NACE
Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies
Overige adviesbureaus op het gebied van bedrijfsvoering en beheer
Handelsbemiddeling in de groothandel in machines, apparaten en werktuigen voor de industrie en in schepen en luchtvaartuigen
Handelsbemiddeling in machines, apparaten en werktuigen voor de industrie en in schepen en luchtvaartuigen
Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering
Handelsbemiddeling in de groothandel in andere specifieke goederen
Verhuur en exploitatie van sociale woningen
Verhuur en exploitatie van eigen of geleased residentieel onroerend goed, exclusief sociale woningen
+7